MKI67 and central nervous system cancer: In AQP4+ glioma cells, the percentage of Ki67+ cells were also significantly greater than that of Ki67- cells (Figure 8F, 85.9% ± 1.8% vs 39.4% ± 2.6%, p < 0.0001, n = 60).